The oligomerization domain of p53: Crystal structure of the trigonal form
Open accessThe DOI matches its Crossref record.
Abstract
The structure of the oligomerization domain of the p53 tumor suppressor protein was determined in the trigonal crystal form, using a refined NMR structure as a model. A synthetic peptide comprising residues 319–360 of human p53 crystallized in the space group P3 1 21. There is one biologically relevant tetrameric domain in the crystallographic asymmetric unit. The structure was refined jointly with NMR data, only the third such case (the previous examples being IL‐1β (Shaanan, B., Gronenborn,, A.M., Cohen, G.H., Gilliland, G.L., Veerapandian, B., Davies, D.R. and Clore, G.M. (1992) Science 257, 961–964 [1]) and BPTI (Schiffer, C., Huber, R., Wuthrich, K. and Van Gunsteren, W.F. (1994) J. Mol. Biol. 241, 588–599 [2])), to 2.5 Å resolution with an R factor of 0.207. The distribution of tumor‐derived mutations in the oligomerization region together with structural and biological data suggest a strategy for the design of antitumor therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
The Tumor Suppressor p53: From Structures to Drug Discovery
Joerger, A. C., & Fersht, A. R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000919 · Cited by 357
The role of tetramerization in p53 function
Chène, P. (2001) · Oncogene · doi:10.1038/sj.onc.1204373 · Cited by 271
Noncanonical DNA Motifs as Transactivation Targets by Wild Type and Mutant p53
Jordan, J. J., Menendez, D., Inga, A., Nourredine, M., Bell, D., & Resnick, M. A. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000104 · Cited by 103
Quantum chemical profiling of protein mutations via fragment-based DFT
Leyva, A., & Niazi, M. K. K. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1770157
Metadata
- Authors
- Miller, M., Lubkowski, J., Mohana Rao, J. K., Danishefsky, A. T., Omichinski, J. G., Sakaguchi, K., Sakamoto, H., Appella, E., Gronenborn, A. M., & Clore, G. M.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 1996-12-09
- Volume
- 399
- Issue
- 1-2
- Pages
- 166-170
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2082755802
- Cited by
- 42
- References
- 0
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The oligomerization domain of p53: Crystal structure of the trigonal form. https://app.cochat.ai/papers/10.1016/s0014-5793(96)01231-8
- The paper
- Miller, M., Lubkowski, J., Mohana Rao, J. K., Danishefsky, A. T., Omichinski, J. G., Sakaguchi, K., Sakamoto, H., Appella, E., Gronenborn, A. M., & Clore, G. M. (1996). The oligomerization domain of p53: Crystal structure of the trigonal form. FEBS Letters. https://doi.org/10.1016/s0014-5793(96)01231-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.